M. Shenglin

Anti-PD-1/PD-L1 Therapy as a Promising Option for Non-Small Cell Lung Cancer: a Single arm Meta-Analysis

B. Wang, Lucheng Zhu, Shirong Zhang, 2016, Pathology & Oncology Research.

Role of transcription factor FOXA 1 in non ‐ small cell lung cancer

L. Jia, Lucheng Zhu, Shirong Zhang, 2022 .

Efficacy, tolerability, and biomarker analyses from a phase III, randomized, placebo-controlled, parallel group study of gefitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) (INFORM; C-TONG 0804).

M. Wang, X. Liu, Y. Cheng, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy, tolerability, and biomarker analyses from a phase III, randomized, placebo-controlled, parallel group study of gefitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC; INFORM; C-TONG 0804).

M. Wang, X. Liu, Y. Cheng, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study

Lucheng Zhu, Zhi-Ping Yang, B. Xia, 2021, BMC Cancer.

Laser micro-milling of microchannel on copper sheet as catalyst support used in microreactor for hydrogen production

Wei Zhou, Lifeng Qin, Longsheng Lu, 2014 .

Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma.

Z. Ke, D. Qinghua, M. Shenglin, 2013, Hepato-gastroenterology.